Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03555630 · ClinicalTrials.gov registry record
Thromboelastogram in Postdelivery Preeclamptic Patients
A clinical trial, sponsored by Augusta University.
- Completed
- Registry status
- 30
- Enrollment target
NCT03555630 is a clinical trial that has completed, run by Augusta University. The registered enrollment target is 30 participants.
The verdict
NCT03555630 has completed, sponsored by Augusta University.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
There are no studies evaluating the effect of aging on hemostasis of preeclamptic patients. Additionally, although there are some studies that establish normal reference values for TEG profiles in healthy term pregnant patients, conflicting results have been found in preeclampsia. Reference values are important to establish baseline parameters in cases of pre-eclampsia complicated by postpartum hemorrhage. The investigators will evaluate reference values for TEG in postdelivery preeclamptic patients and the difference between vaginal delivery and cesarean section.
Interventions
- DIAGNOSTIC_TEST Thromboelastogram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-05-22 |
| Est. Completion | 2019-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03555630
The ClinicalTrials.gov registry entry for NCT03555630 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Augusta University, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Thromboelastogram is the first listed.
NCT03555630 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03555630 about?
NCT03555630 is a clinical study titled "Thromboelastogram in Postdelivery Preeclamptic Patients". There are no studies evaluating the effect of aging on hemostasis of preeclamptic patients. Additionally, although there are some studies that establish normal reference values for TEG profiles in healthy term pregnant patients, conflicting results have been found in preeclampsia. Reference values a...
What is the current status of trial NCT03555630?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2018-05-22. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03555630?
The interventions under investigation include: Thromboelastogram (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03555630?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.